Rudi Mariën

PharmaFluidics-Rudi-Marien

Rudi Mariën

Rudi Mariën is an emblematic pioneer and entrepreneur in the Belgian life sciences scene. He was founder, reference shareholder and managing director of BARC group, a clinical research lab and of biotech company Innogenetics, prior to their acquisitions by Cerba and Fujirebio, respectively. Mr. Mariën was a part of many successful regional and international life sciences ventures, both listed and privately held, as investor and deal-maker; these include a.o. Devgen (later acquired by Syngenta), Biocartis, MyCartis, Multiplicom (later acquired by Agilent), Actogenix (later acquired by Intrexon).